HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease

[1]  Das Rückenmuskelphänomen beim Sprechen. , 1906 .

[2]  D. Bell,et al.  Alzheimer's disease and HLA. , 1978, Tissue antigens.

[3]  Histocompatibility Antigens in Alzheimer’s Disease , 1980 .

[4]  HLA antigens in senile dementia and multiple infarct dementia. , 1981, Age and ageing.

[5]  C. Eisdorfer,et al.  Histocompatibility antigens (HLA) and patterns of cognitive loss in dementia of the Alzheimer type , 1981, Neurobiology of Aging.

[6]  Lack of association between Alzheimer's disease and histocompatibility antigens. , 2008, Tissue antigens.

[7]  HLA antigens in Alzheimer's disease. , 2008, Tissue antigens.

[8]  E. Renvoize.  An HLA and family study of Alzheimer's disease , 1984, Psychological Medicine.

[9]  G. Small,et al.  HLA-A2 as a possible marker for early-onset Alzheimer disease in men , 1986, Neurobiology of Aging.

[10]  H. Endo,et al.  HLA system in senile dementia of Alzheimer type and multi-infarct dementia in Japan. , 1986, Archives of gerontology and geriatrics.

[11]  M. Roth.  CAMDEX : the Cambridge examination for mental disorders of the elderly , 1999 .

[12]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[13]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[14]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[15]  M. Frecker,et al.  Immunological Associations in Familial and Non-Familial Alzheimer Patients and Their Families , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  H. Hsieh-Li,et al.  Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. , 1994, Cellular immunology.

[17]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[18]  D. Premkumar,et al.  Molecular aspects of inflammatory and immune responses in Alzheimer's disease , 1996, Neurobiology of Aging.

[19]  F. S. Jensen,et al.  Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. , 1996, Human heredity.

[20]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[21]  Douglas Walker,et al.  Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.

[22]  I. McKeith,et al.  HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease , 1997, Neuroreport.

[23]  K. Welsh,et al.  Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin , 1997 .

[24]  R. Mahley,et al.  Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro , 1997, Brain Research.

[25]  A. Smith,et al.  Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. , 1997, Human molecular genetics.

[26]  G. Schellenberg,et al.  Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease , 1997, Neurology.

[27]  M. Barnardo,et al.  High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. , 1996, Tissue antigens.

[28]  A. Oterino,et al.  Short communication Association of the HLA‐A2 allele with an earlier age of onset of Alzheimer's disease , 1998 .

[29]  D. Laskowitz,et al.  Endogenous apolipoprotein E suppresses LPS‐stimulated microglial nitric oxide production , 1998, Neuroreport.

[30]  J. Haines,et al.  No association between the HLA-A2 allele and Alzheimer disease , 1999, Neurogenetics.

[31]  S. Sorbi,et al.  HLA A2 allele is associated with age at onset of Alzheimer's disease , 1999, Annals of neurology.

[32]  H. Wiebusch,et al.  Further evidence for a synergistic association between APOEɛ4 and BCHE-K in confirmed Alzheimer’s disease , 1999, Human Genetics.

[33]  K. Morgan,et al.  Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease , 1999, European Journal of Human Genetics.

[34]  P. Ince,et al.  Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03 , 1999, Neuroscience Letters.

[35]  P. Ince,et al.  Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease , 1999, Neuroscience Letters.